CompBrief BY VELARION

Companies Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals (TNXP): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Tonix Pharmaceuticals Holding’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.
CEO total pay$3,168,830CEO Seth Lederman · source
Say-on-pay support77.84%Latest vote · source
CEO pay ratio2:1To the median employee · source

CEO pay, last three years

  • $2,050,065FY2023
  • $1,809,767FY2024
  • $3,168,830FY2025

CEO total pay was $3,168,830 in fiscal 2025, up from $1,809,767 in fiscal 2024.

FY2025: salary $702,000 · bonus $596,700 · stock awards $0 · option awards $1,870,130

Executives and directors

Frequently asked questions

Who was the highest-paid executive at Tonix Pharmaceuticals Holding in fiscal 2025?
As disclosed, Seth Lederman (Chief Executive Officer) was the highest-paid executive at Tonix Pharmaceuticals Holding in fiscal 2025, with total compensation of $3,168,830.
What is Tonix Pharmaceuticals Holding's CEO-to-median employee pay ratio?
As disclosed, Tonix Pharmaceuticals Holding's CEO-to-median employee pay ratio was 2:1.
How did shareholders vote on Tonix Pharmaceuticals Holding's executive compensation?
As disclosed, 77.84% of shareholders supported Tonix Pharmaceuticals Holding's executive compensation in the latest say-on-pay vote.
How much does Tonix Pharmaceuticals Holding spend in total on board compensation for fiscal 2025?
As disclosed, Tonix Pharmaceuticals Holding reported total board compensation of $435,250 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Seth Lederman$702,000$596,700$0$1,870,130$0$0$0$3,168,830
Chief Executive Officer
Jessica Morris522,912261,4500441,9070001,226,269
Chief Operations Officer
Gregory Sullivan519,168259,6000437,7740001,216,542
Chief Medical Officer
Bradley Saenger502,944251,4500389,1190001,143,513
Chief Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Seth Lederman$3,168,830$1,809,767$2,050,065↑ +1,359,063
Jessica Morris1,226,269887,741928,599↑ +338,528
Gregory Sullivan1,216,542922,444951,998↑ +294,098
Bradley Saenger1,143,513849,981904,913↑ +293,532

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

The company's compensation program is designed to enhance shareholder value by attracting, motivating, and retaining qualified individuals. It emphasizes pay-for-performance, linking compensation to individual and corporate performance, and uses equity as a key component to align executive interests with shareholders.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultantAon plc
Clawback policy—
Anti-hedgingtrue
Anti-pledgingtrue
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Jessica MorrisOPTION2025-02-25——29,291—$220,116
Bradley SaengerOPTION2025-02-25——25,792—195,297
Gregory SullivanOPTION2025-02-25——29,017—219,717
Gregory SullivanOPTION2025-02-25——29,017—218,057
Seth LedermanOPTION2025-02-25——123,958—931,520
Seth LedermanOPTION2025-02-25——123,958—938,610
Jessica MorrisOPTION2025-02-25——29,291—221,791
Bradley SaengerOPTION2025-02-25——25,792—193,822

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Jessica Morris$0$0$441,9070.0%
Bradley Saenger00389,1190.0%
Gregory Sullivan00437,7740.0%
Seth Lederman001,870,1300.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Bradley SaengerOption25,7928.05—
Bradley SaengerOption25,79210.06—
Gregory SullivanOption29,0178.05—
Gregory SullivanOption29,01710.06—
Jessica MorrisOption29,2918.05—
Jessica MorrisOption29,29110.06—
Seth LedermanOption123,9588.05—
Seth LedermanOption123,95810.06—
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
James HunterIndependent$30,250—$249,957——$280,207
James TrecoIndependent · Lead Independent Director · Audit (Chair) · Nominating and Corporate Governance75,000—188,830——263,830
Margaret Smith BellIndependent · Audit · Compensation (Chair)55,000—188,830——243,830
Adeoye OlukotunIndependent · Compensation55,000—188,830——243,830
Newcomb StillwellIndependent · Audit · Nominating and Corporate Governance55,000—188,830——243,830
Richard BaggerIndependent · Audit · Nominating and Corporate Governance (Chair)55,000—188,830——243,830
David GrangeIndependent · Compensation · Nominating and Corporate Governance55,000—188,830——243,830
Carolyn TaylorIndependent · Compensation55,000—188,830——243,830
Seth LedermanEmployee director · Board Chair—————0

Board fee structure and ownership guideline

Annual cash retainer$55,000
Annual equity retainer$188,830
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)—
Stock ownership guideline—

Total cost of the board

ComponentFY2025
Cash retainers and fees$435,250
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$435,250

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Tonix Pharmaceuticals as a peer

Companies that benchmark against TNXP

No companies currently name TNXP as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Tonix Pharmaceuticals Holding2025Seth Lederman$702,000$0$1,870,130$0$3,168,830

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20252025-05-081,045,066297,523162,59577.84%Passed
20192019-05-03695,330140,89411,72782%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20252025-05-0877.84%a
20192019-05-0382%b

a. Approved under the standard stated in the filing — “Approval of all other matters requires the affirmative vote of a majority of the votes cast on the applicable matter at the Annual Meeting in person via attendance at the virtual Annual Meeting or by proxy. || Abstentions: Abstentions, broker non-votes and directions to withhold authority will not be counted as votes cast and accordingly will have no effect on the outcome of any proposal.”.

b. Approved under the standard stated in the filing — “Approval of this resolution requires the affirmative vote of the holders of a majority of the votes cast in person or by proxy at the Annual Meeting. || Abstentions: Abstentions and broker non-votes will not be counted as votes with respect to any matter, but may have the effect of a vote against certain matters to come before the meeting, as described elsewhere in this Proxy.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)2 : 1
CEO total compensation$3,168,830
Median employee compensation—
Insider trades since the proxy

No insider equity transactions reported since the proxy statement.

Sources (28 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Seth Lederman. DEF 14A, filed 2026-03-30. Section “Summary Compensation Table” · page 39. As printed: 3,168,830. View filing ↗
  • Section 01, Jessica Morris. DEF 14A, filed 2026-03-30. Section “Summary Compensation Table” · page 40. As printed: 1,226,269. View filing ↗
  • Section 01, Gregory Sullivan. DEF 14A, filed 2026-03-30. Section “Summary Compensation Table” · page 40. As printed: 1,216,542. View filing ↗
  • Section 01, Bradley Saenger. DEF 14A, filed 2026-03-30. Section “Summary Compensation Table” · page 40. As printed: 1,143,513. View filing ↗
  • Section 03, Jessica Morris OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Bradley Saenger OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Gregory Sullivan OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Gregory Sullivan OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Seth Lederman OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Seth Lederman OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Jessica Morris OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 03, Bradley Saenger OPTION. DEF 14A, filed 2026-03-30. Section “Grants of Plan-Based Awards in Fiscal 2025” · grants of plan-based awards table. View filing ↗
  • Section 07, pay ratio. DEF 14A, filed 2026-03-30. Section “CEO Pay Ratio”. As printed: 2 : 1. View filing ↗
  • Section 08, James Hunter. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 280,207. View filing ↗
  • Section 08, James Treco. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 263,830. View filing ↗
  • Section 08, Margaret Smith Bell. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 243,830. View filing ↗
  • Section 08, Adeoye Olukotun. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 243,830. View filing ↗
  • Section 08, Newcomb Stillwell. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 243,830. View filing ↗
  • Section 08, Richard Bagger. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 243,830. View filing ↗
  • Section 08, David Grange. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 243,830. View filing ↗
  • Section 08, Carolyn Taylor. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 243,830. View filing ↗
  • Section 08, Seth Lederman. DEF 14A, filed 2026-03-30. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-05-08. Item 5.07 · say-on-pay result. As reported: 77.84% (votes for as printed: 1,045,066). View filing ↗
  • Section 06, 2019 vote. Form 8-K, filed 2019-05-08. Item 5.07 · say-on-pay result. As reported: 82% (votes for as printed: 695,330). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
  • Section 09b board cost (computed). Computed. Cash 435,250 + equity 0 + all other 0 = 435,250, summed across the director compensation table rows.
  • Tonix Pharmaceuticals Holding (subject), Section 10b CEO total. DEF 14A, filed 2026-03-30. CEO total compensation as printed in Tonix Pharmaceuticals Holding's own proxy. As printed: 3,168,830. View filing ↗
Get the full report — $500